Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vestn Ross Akad Med Nauk ; (7): 15-8, 2010.
Artigo em Russo | MEDLINE | ID: mdl-20795397

RESUMO

Immunohistochemical studies revealed the dependence of cell regeneration parameters at sites of intestinal metaplasia (IM) in gastric mucosa (GM) on the character of the background events, such as atrophy and erosive-ulcerative defect. Mucin profile was determined in various types of IM. The intestinal type of mucin was found only in type I IM while types II and III were characterized by the mixed gastrointestinal phenotype with expression MUCSAC and MUC2. It was shown that at sites of incomplete IM (types II and III) and atrophic changes of GM cells proliferation activity of epithelium is considerably increased; this increase may be associated with the risk of developing gastric cancer of the intestinal type.


Assuntos
Mucosa Gástrica/patologia , Gastrite Atrófica/patologia , Mucosa Intestinal/patologia , Mucinas/biossíntese , Úlcera Gástrica/patologia , Adulto , Proliferação de Células , Células Epiteliais/patologia , Feminino , Mucosa Gástrica/microbiologia , Gastrite Atrófica/complicações , Gastrite Atrófica/microbiologia , Helicobacter pylori/isolamento & purificação , Humanos , Mucosa Intestinal/microbiologia , Masculino , Metaplasia/complicações , Metaplasia/microbiologia , Metaplasia/patologia , Pessoa de Meia-Idade , Úlcera Gástrica/complicações , Úlcera Gástrica/microbiologia
2.
Arkh Patol ; 67(3): 17-21, 2005.
Artigo em Russo | MEDLINE | ID: mdl-16075606

RESUMO

It is shown with the use of immunohistochemical detection of Bcl-2, caspase-3 and Ki-67 that eradication of HP does not result in immediate reverse development of atrophic changes. This depends on duration of persistence of mononuclear inflammatory cells.


Assuntos
Caspases/análise , Gastrite Atrófica/imunologia , Infecções por Helicobacter/terapia , Helicobacter pylori , Antígeno Ki-67/análise , Proteínas Proto-Oncogênicas c-bcl-2/análise , Regeneração , Estômago/fisiologia , Apoptose , Caspase 3 , Doença Crônica , Gastrite Atrófica/etiologia , Infecções por Helicobacter/complicações , Humanos , Monócitos/imunologia , Estômago/imunologia , Estômago/patologia
3.
Ter Arkh ; 75(11): 71-3, 2003.
Artigo em Russo | MEDLINE | ID: mdl-14708448

RESUMO

AIM: To study the efficiency of one-week antihelicobacter therapy using omeprazole, clarithromycin, and amoxycillin in patients with duodenal peptic ulcer during its recurrence. MATERIALS AND METHODS: 105 patients with recurrent peptic ulcer and a not less than 0.5-cm ulcer in the duodenal bulb was given triple therapy: omeprazole, 20 mg twice daily, amoxycillin, 1000 mg twice daily, and clarithromycin, 500 mg twice daily for 7 days. Then the patients were allowed to take antacids if they were required to abolish the symptoms of recurrent peptic ulcer. H. pylori was detected in the mucosal biopsy specimens taken from the anthral part and body of the stomach at gastroduodenascopy, by using the rapid urease test and histology. Gastroduodenoscopy was performed before and 4-6 weeks after the triple therapy. RESULTS: The major symptoms of recurrent peptic ulcer were eliminated in 90% of the patients by the end of a course of therapy, i.e. on its day 7. By the control time, the rate of ulcer cicatrization was 99.05% (104/105). The coincidence of results of the two tests has indicated that H. pylori eradication was 81.9% (86/105) 4-6 weeks after termination of treatment. Adverse reactions during therapy were observed in 20% of the patients; however, treatment had to be discontinued only in 2.9% of the patients. CONCLUSION: One-week triple therapy using omeprazole, clarithromycin, and amoxycillin in highly effective in treating duodenal peptic ulcer during its recurrence.


Assuntos
Antibacterianos/uso terapêutico , Antiulcerosos/uso terapêutico , Úlcera Duodenal/tratamento farmacológico , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori/efeitos dos fármacos , Adolescente , Adulto , Idoso , Amoxicilina/administração & dosagem , Amoxicilina/uso terapêutico , Antibacterianos/administração & dosagem , Antiulcerosos/administração & dosagem , Claritromicina/administração & dosagem , Claritromicina/uso terapêutico , Esquema de Medicação , Quimioterapia Combinada , Úlcera Duodenal/etiologia , Úlcera Duodenal/microbiologia , Feminino , Infecções por Helicobacter/complicações , Infecções por Helicobacter/microbiologia , Helicobacter pylori/isolamento & purificação , Humanos , Masculino , Pessoa de Meia-Idade , Omeprazol/administração & dosagem , Omeprazol/uso terapêutico , Federação Russa , Resultado do Tratamento
4.
Biull Eksp Biol Med ; 108(8): 247-50, 1989 Aug.
Artigo em Russo | MEDLINE | ID: mdl-2804336

RESUMO

By methods of immunohistochemistry, light and electron microscopies gastrobiopsies from regions of acute and chronic erosions and border zones of gastric mucosa were studied in 36 patients with erosive gastritis. There was determined the decrease of amount of IgA-producing cells against a background of the increase of IgG-producing plasmocytes in the zone of mucosal defect. IgG-precipitations and fixation of heterogeneous complement in fibrinoid necrosis of erosive defect were revealed. Mucosal microcirculatory disturbances stipulated by immunocomplex injuries are found to be mosaic. There is given proof of the role of second local immunity disturbances in origin and chronization of erosive defects of gastric mucosa.


Assuntos
Mucosa Gástrica/patologia , Gastrite/diagnóstico , Adulto , Complexo Antígeno-Anticorpo/análise , Biópsia , Proteínas do Sistema Complemento/análise , Diagnóstico Diferencial , Mucosa Gástrica/imunologia , Gastrite/imunologia , Gastrite/patologia , Humanos , Imunoglobulina A/análise , Imunoglobulina G/análise , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Necrose
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...